Target intelligence / Profile preview

RNA, U6 small nuclear 307, pseudogene (RNU6-307P)

Target
RNU6-307P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene, Noncoding RNA
01

Overview

**RNA, U6 small nuclear 307, pseudogene (RNU6-307P)** is a *pseudogene*—a nonfunctional genomic copy—of the gene encoding U6 small nuclear RNA, which is a component of the spliceosomal machinery (complex responsible for pre-mRNA splicing in eukaryotes).[1][3] Pseudogenes like RNU6-307P arise through retrotransposition and contain sequence similarity to functional snRNA genes but lack functional elements, such as promoters, for stable expression or correct processing.[3] Such pseudogenes do not encode proteins or participate in recognized cellular pathways and are considered evolutionary relics rather than active therapeutic targets or biomarkers.[1][3][4] **Key notes:** - This entry refers to a *pseudogene* and not a protein-coding gene, enzyme, receptor, or typical drug target.[1][3] - The canonical U6 small nuclear RNA, from which it derives, is essential for splicing, but pseudogene variants are nonfunctional.[3] - There is no evidence that RNU6-307P is involved in disease or that drugs interact with it. - Pseudogene transcripts (in rare cases) might regulate gene expression, but specific regulatory roles for RNU6-307P are unknown and not documented in current data.[4] If structured data is required for processing, most biomedical and drug development pipelines would designate "is_target: false" for pseudogenes like RNU6-307P.

Other names
RNU6-307PRNA, U6 Small Nuclear 307, Pseudogene
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene; original U6 snRNA is involved in pre-mRNA splicing, but pseudogenes are generally nonfunctional)[1][3]
04

Disease associations

None known (no documented direct association with disease processes)[1][3]

Beyond the preview

Go deeper on RNA, U6 small nuclear 307, pseudogene (RNU6-307P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 307, pseudogene (RNU6-307P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call